Kevin Feeley - 30 Sep 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Bridget Brown, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
30 Sep 2025
Net transactions value
-$675,554
Form type
4
Filing time
01 Oct 2025, 16:18:24 UTC
Previous filing
18 Sep 2025
Next filing
31 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feeley Kevin CHIEF FINANCIAL OFFICER C/O GENEDX HOLDINGS CORP., STAMFORD /s/ Bridget Brown, Attorney-in-Fact 01 Oct 2025 0001944119

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $40,707 +1,246 +14% $32.67 10,001 30 Sep 2025 Direct F1
transaction WGS Class A Common Stock Sale $36,203 -344 -3.4% $105.24 9,657 30 Sep 2025 Direct F1, F2
transaction WGS Class A Common Stock Sale $41,354 -387 -4% $106.86 9,270 30 Sep 2025 Direct F1, F3
transaction WGS Class A Common Stock Sale $292,361 -2,715 -29% $107.68 6,555 30 Sep 2025 Direct F1, F4
transaction WGS Class A Common Stock Sale $233,851 -2,152 -33% $108.67 4,403 30 Sep 2025 Direct F1, F5
transaction WGS Class A Common Stock Sale $46,330 -421 -9.6% $110.05 3,982 30 Sep 2025 Direct F1, F6
transaction WGS Class A Common Stock Sale $58,204 -520 -13% $111.93 3,462 30 Sep 2025 Direct F1, F7
transaction WGS Class A Common Stock Sale $7,958 -70 -2% $113.68 3,392 30 Sep 2025 Direct F1, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Employee Stock Option (Right to Buy) Options Exercise $0 -1,246 -20% $0.000000 4,982 30 Sep 2025 Class A Common Stock 1,246 $32.67 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.1354 to $107.01, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.22 to $108.20, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.23 to $109.1754, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.3225 to $110.25, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive.
F8 Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 3,392 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 124,633 shares of Class A common stock and options to purchase up to an aggregate of 25,906 shares of Class A common stock, which RSUs and options vest according to their respective terms.
F9 The award vested or vests as to 6.25% of the total award quarterly over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.